These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24809782)

  • 1. SERPINB3 is associated with TGF-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognosis.
    Turato C; Vitale A; Fasolato S; Ruvoletto M; Terrin L; Quarta S; Ramirez Morales R; Biasiolo A; Zanus G; Zali N; Tan PS; Hoshida Y; Gatta A; Cillo U; Pontisso P
    Br J Cancer; 2014 May; 110(11):2708-15. PubMed ID: 24809782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SerpinB3 upregulates the Cyclooxygenase-2 / β-Catenin positive loop in colorectal cancer.
    Terrin L; Agostini M; Ruvoletto M; Martini A; Pucciarelli S; Bedin C; Nitti D; Pontisso P
    Oncotarget; 2017 Feb; 8(9):15732-15743. PubMed ID: 28178650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SERPINB3 modulates TGF-beta expression in chronic liver disease.
    Turato C; Calabrese F; Biasiolo A; Quarta S; Ruvoletto M; Tono N; Paccagnella D; Fassina G; Merkel C; Harrison TJ; Gatta A; Pontisso P
    Lab Invest; 2010 Jul; 90(7):1016-23. PubMed ID: 20212457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SerpinB3 induces dipeptidyl-peptidase IV/CD26 expression and its metabolic effects in hepatocellular carcinoma.
    Fasolato S; Trevellin E; Ruvoletto M; Granzotto M; Zanus G; Boscaro E; Babetto E; Terrin L; Battocchio MA; Ciscato F; Turato C; Quarta S; Cillo U; Pontisso P; Vettor R
    Life Sci; 2018 May; 200():134-141. PubMed ID: 29524519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells.
    Cannito S; Turato C; Paternostro C; Biasiolo A; Colombatto S; Cambieri I; Quarta S; Novo E; Morello E; Villano G; Fasolato S; Musso T; David E; Tusa I; Rovida E; Autelli R; Smedile A; Cillo U; Pontisso P; Parola M
    Oncotarget; 2015 Feb; 6(4):2206-21. PubMed ID: 25544768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of p53 and β-catenin mutations in conjunction with CK19 expression on early tumor recurrence and prognosis of hepatocellular carcinoma.
    Yuan RH; Jeng YM; Hu RH; Lai PL; Lee PH; Cheng CC; Hsu HC
    J Gastrointest Surg; 2011 Feb; 15(2):321-9. PubMed ID: 21061181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of combined TGF-β1 and ELF in hepatocellular carcinoma.
    Ji F; Fu SJ; Shen SL; Zhang LJ; Cao QH; Li SQ; Peng BG; Liang LJ; Hua YP
    BMC Cancer; 2015 Mar; 15():116. PubMed ID: 25880619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of SERPINB3 in hepatocellular carcinoma.
    Pontisso P
    Ann Hepatol; 2014; 13(6):722-7. PubMed ID: 25332258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of micro RNA-135A in hepatocellular carcinoma is associated with recurrence within 12 months after resection.
    von Felden J; Heim D; Schulze K; Krech T; Ewald F; Nashan B; Lohse AW; Wege H
    BMC Cancer; 2017 Jan; 17(1):60. PubMed ID: 28100188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low expression of c-Myc protein predicts poor outcomes in patients with hepatocellular carcinoma after resection.
    Ji F; Zhang ZH; Zhang Y; Shen SL; Cao QH; Zhang LJ; Li SQ; Peng BG; Liang LJ; Hua YP
    BMC Cancer; 2018 Apr; 18(1):460. PubMed ID: 29690860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoplasmic and/or nuclear expression of β-catenin correlate with poor prognosis and unfavorable clinicopathological factors in hepatocellular carcinoma: a meta-analysis.
    Chen J; Liu J; Jin R; Shen J; Liang Y; Ma R; Lin H; Liang X; Yu H; Cai X
    PLoS One; 2014; 9(11):e111885. PubMed ID: 25401330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs and SerpinB3 in hepatocellular carcinoma.
    Turato C; Simonato D; Quarta S; Gatta A; Pontisso P
    Life Sci; 2014 Mar; 100(1):9-17. PubMed ID: 24496037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-expression of LASS2 and TGF-β1 predicts poor prognosis in hepatocellular carcinoma.
    Ruan H; Wang T; Yang C; Jin G; Gu D; Deng X; Wang C; Qin W; Jin H
    Sci Rep; 2016 Sep; 6():32421. PubMed ID: 27581744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated expression of DKK1 is associated with cytoplasmic/nuclear beta-catenin accumulation and poor prognosis in hepatocellular carcinomas.
    Yu B; Yang X; Xu Y; Yao G; Shu H; Lin B; Hood L; Wang H; Yang S; Gu J; Fan J; Qin W
    J Hepatol; 2009 May; 50(5):948-57. PubMed ID: 19303159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.
    Fan QM; Jing YY; Yu GF; Kou XR; Ye F; Gao L; Li R; Zhao QD; Yang Y; Lu ZH; Wei LX
    Cancer Lett; 2014 Oct; 352(2):160-8. PubMed ID: 24892648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity.
    Turato C; Cannito S; Simonato D; Villano G; Morello E; Terrin L; Quarta S; Biasiolo A; Ruvoletto M; Martini A; Fasolato S; Zanus G; Cillo U; Gatta A; Parola M; Pontisso P
    Sci Rep; 2015 Dec; 5():17701. PubMed ID: 26634820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined Chibby and β-Catenin Predicts Clinical Outcomes in Patients with Hepatocellular Carcinoma.
    Tsai MC; Huang CC; Wei YC; Liu TT; Lin MT; Yi LN; Lin PR; Wang CC; Chu TH; Hsiao CC; Hu TH; Tai MH
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-214 targets β-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma.
    Xia H; Ooi LL; Hui KM
    PLoS One; 2012; 7(9):e44206. PubMed ID: 22962603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of a TGF-β1-CD147 self-sustaining network in the differentiation plasticity of hepatocellular carcinoma cells.
    Wu J; Lu M; Li Y; Shang YK; Wang SJ; Meng Y; Wang Z; Li ZS; Chen H; Chen ZN; Bian H
    Oncogene; 2016 Oct; 35(42):5468-5479. PubMed ID: 27041581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of fibroblast growth factor 19 is associated with recurrence and poor prognosis of hepatocellular carcinoma.
    Hyeon J; Ahn S; Lee JJ; Song DH; Park CK
    Dig Dis Sci; 2013 Jul; 58(7):1916-22. PubMed ID: 23456506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.